Oncimmune Holdings (ONC)

15.15p
   
  • Change Today:
      0.050p
  • 52 Week High: 29.10p
  • 52 Week Low: 9.58p
  • Currency: UK Pounds
  • Shares Issued: 111.77m
  • Volume: 101,185
  • Market Cap: £16.93m

ONC Overview

We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum. Using our unique expertise and proprietary technology we aim to transform the way disease is diagnosed and treated around the world. We know that detecting the disease early can improve the ability to treat cancer and enhance chances of survival.

Key Personnel

CEO: Martin Gouldstone
Non-Executive Chairman: Alistair Macdonald
Senior Independent Non-Executive Director: Sally Waterman
Non-Executive Dir: John Goold

Contact Details

Address: MediCity – D6 Building, 1 Thane Road, Nottingham, United Kingdom, NG90 6BH
Phone: +44 1157 840 500
Website: http://oncimmune.com

Listings

Index: FTSE AIM All-Share
ISIN: GB00BYQ94H38

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ONC Market Data

Currency UK Pounds
Share Price 15.15p
Change Today 0.050p
% Change 0.33 %
52 Week High 29.10p
52 Week Low 9.58p
Volume 101,185
Shares Issued 111.77m
Market Cap £16.93m

ONC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

ONC Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
12:06 27,500 @ 15.14p
12:05 10,471 @ 15.10p
12:05 28,214 @ 15.10p
12:03 25,000 @ 15.24p

ONC Key Personnel

CEO Martin Gouldstone

Top of Page